{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:51:09Z","timestamp":1774533069600,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"High-Tech Research Center"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.mce.2012.05.002","type":"journal-article","created":{"date-parts":[[2012,5,10]],"date-time":"2012-05-10T09:21:41Z","timestamp":1336641701000},"page":"219-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Bisphosphonate- and statin-induced enhancement of OPG expression and inhibition of CD9, M-CSF, and RANKL expressions via inhibition of the Ras\/MEK\/ERK pathway and activation of p38MAPK in mouse bone marrow stromal cell line ST2"],"prefix":"10.1016","volume":"361","author":[{"given":"Masanobu","family":"Tsubaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Satou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuki","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiro","family":"Imano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Yanae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisato","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risa","family":"Takagoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Komai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shozo","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2012.05.002_b0005","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1182\/blood.V93.8.2586","article-title":"Stromal cell CD9 regulates differentiation of hematopoietic stem\/progenitor cells","volume":"93","author":"Aoyama","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.mce.2012.05.002_b0010","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/jcb.10507","article-title":"Proliferation and differentiation of osteoblasts and adipocytes in rat bone marrow stromal cell cultures: effects of dexamethasone and calcitriol","volume":"89","author":"Atmani","year":"2003","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.mce.2012.05.002_b0015","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1592\/phco.30.9.879","article-title":"Synergistic effect of statins and postmenopausal hormone therapy in the prevention of skeletal fractures in elderly women","volume":"30","author":"Bakhireva","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.mce.2012.05.002_b0020","doi-asserted-by":"crossref","first-page":"8352","DOI":"10.1073\/pnas.140021997","article-title":"Phosphate is a specific signal for induction of osteopontin gene expression","volume":"97","author":"Beck","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mce.2012.05.002_b0025","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.mce.2012.05.002_b0030","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1074\/jbc.271.10.5289","article-title":"Protein prenytransferase","volume":"271","author":"Casey","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2012.05.002_b0035","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.bone.2009.12.023","article-title":"Effects of statins vs. non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia","volume":"46","author":"Chuengsamarn","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.mce.2012.05.002_b0040","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00198-009-1129-1","article-title":"Alendronate reduces osteoclast precursors in osteoporosis","volume":"21","author":"D\u2019Amelio","year":"2010","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.mce.2012.05.002_b0045","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00198-005-0035-4","article-title":"Changes in the RANK ligand\/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients","volume":"17","author":"Dobnig","year":"2006","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.mce.2012.05.002_b0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00223-001-2017-7","article-title":"Statins and bone: myth or reality?","volume":"69","author":"Edwards","year":"2001","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.mce.2012.05.002_b0055","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00223-011-9473-5","article-title":"Reduced osteoclastogenesis and RANKL expression in marrow from women taking alendronate","volume":"88","author":"Eslami","year":"2011","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.mce.2012.05.002_b0060","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/jcb.22676","article-title":"The increased expression of receptor activator of nuclear-kappaB ligand (RANKL) of multiple myeloma bone marrow stromal cells is inhibited by the bisphosphonate ibandronate","volume":"111","author":"Fern\u00e1ndez","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.mce.2012.05.002_b0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1248\/yakushi.128.153","article-title":"Fluvastatin induces apoptosis on human tongue carcinoma cell line HSC-3","volume":"128","author":"Fujiwara","year":"2008","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.mce.2012.05.002_b0070","doi-asserted-by":"crossref","first-page":"8648","DOI":"10.1158\/1078-0432.CCR-04-1568","article-title":"3-Hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis","volume":"10","author":"Horiguchi","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mce.2012.05.002_b0075","doi-asserted-by":"crossref","first-page":"47366","DOI":"10.1074\/jbc.M208284200","article-title":"U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells","volume":"277","author":"Hotokezaka","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2012.05.002_b0080","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1172\/JCI114100","article-title":"Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow","volume":"83","author":"Hughes","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2012.05.002_b0085","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bone.2006.07.012","article-title":"Glucocorticoids induce the differentiation of a mesenchymal progenitor cell line, ROB-C26 into adipocytes and osteoblasts, but fail to induce terminal osteoblast differentiation","volume":"40","author":"Ito","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.mce.2012.05.002_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4615-5901-6_1","article-title":"Signaling molecules derived from the cholesterol biosynthetic pathway","volume":"28","author":"Jackson","year":"1997","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.mce.2012.05.002_b0095","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1055\/s-2005-870538","article-title":"Statins modulate the levels of osteoprotegerin\/receptor activator of NFkappaB ligand mRNA in mouse bone-cell cultures","volume":"37","author":"Kaji","year":"2005","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.mce.2012.05.002_b0100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jcp.20036","article-title":"Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation","volume":"200","author":"Karst","year":"2004","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.mce.2012.05.002_b0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1385\/ENDO:24:2:121","article-title":"Atorvastatin enhances bone density in ovariectomized rats given 17beta-estradiol or human parathyroid hormone(1\u201334)","volume":"24","author":"Kawane","year":"2004","journal-title":"Endocrine"},{"key":"10.1016\/j.mce.2012.05.002_b0110","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1440-169X.2008.01052.x","article-title":"In vitro response of primary human bone marrow stromal cells to recombinant human bone morphogenic protein-2 in the early and late stages of osteoblast differentiation","volume":"50","author":"Kim","year":"2008","journal-title":"Dev. Growth Differ."},{"key":"10.1016\/j.mce.2012.05.002_b0115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/emm.2002.21","article-title":"Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression","volume":"34","author":"Kim","year":"2002","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.mce.2012.05.002_b0120","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.yexmp.2008.02.004","article-title":"Osteoprotegerin\/RANK\/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease","volume":"84","author":"Liu","year":"2008","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.mce.2012.05.002_b0125","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.metabol.2004.01.010","article-title":"Simvastatin increases bone mineral density in hypercholesterolemic postmenopausal women","volume":"53","author":"Lupattelli","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.mce.2012.05.002_b0130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00018-005-5298-6","article-title":"Isoprenylated proteins","volume":"63","author":"McTaggart","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.mce.2012.05.002_b0135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/jcp.22017","article-title":"Bone morphogenetic protein 2 and dexamethasone synergistically increase alkaline phosphatase levels through JAK\/STAT signaling in C3H10T1\/2 cells","volume":"223","author":"Mikami","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.mce.2012.05.002_b0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jsbmb.2004.03.077","article-title":"Identification of vitamin D target genes in human keratinocytes by subtractive screening","volume":"89\u201390","author":"Moll","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2012.05.002_b0145","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/0003319708330525","article-title":"Effects of pravastatin on serum osteoprotegerin levels in patients with hypercholesterolemia and type 2 diabetes","volume":"61","author":"Mori","year":"2010","journal-title":"Angiology"},{"key":"10.1016\/j.mce.2012.05.002_b0150","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.286.5446.1946","article-title":"Stimulation of bone formation in vitro and in rodents by statins","volume":"286","author":"Mundy","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.mce.2012.05.002_b0155","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1006\/bbrc.1999.0524","article-title":"Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation","volume":"257","author":"Nagai","year":"1999","journal-title":"Biochem. Biophy. Res. Commun."},{"key":"10.1016\/j.mce.2012.05.002_b0160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/bbrc.1999.1621","article-title":"Basic fibroblast growth factor inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D(3) through suppressing the production of osteoclast differentiation factor","volume":"265","author":"Nakagawa","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2012.05.002_b0165","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1006\/bbrc.2000.3379","article-title":"Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines","volume":"275","author":"Nakashima","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2012.05.002_b0170","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.clinbiochem.2010.08.012","article-title":"Lovastatin raises serum osteoprotegerin level in people with type 2 diabetic nephropathy","volume":"43","author":"Nezami","year":"2010","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.mce.2012.05.002_b0175","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1016\/S0024-3205(03)00664-7","article-title":"A new bisphosphonate, YM529 induces apoptosis in HL60 cells by decreasing phosphorylation of single survival signal ERK","volume":"73","author":"Nishida","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.mce.2012.05.002_b0180","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbrc.2004.12.145","article-title":"Nitrogen-containing bisphosphonate, YM529\/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2","volume":"328","author":"Nishida","year":"2005","journal-title":"Biochem. Biophy. Res. Commun."},{"key":"10.1016\/j.mce.2012.05.002_b0185","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11010-005-3086-0","article-title":"Mevastatin induces apoptosis in HL60 cells dependently on decrease in phosphorylated ERK","volume":"269","author":"Nishida","year":"2005","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.mce.2012.05.002_b0190","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1359\/jbmr.080109","article-title":"RANKL inhibition with osteoprotegerin increases bone strength by improving with cortical and trabecular bone architecture in ovariectomized rats","volume":"23","author":"Ominsky","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.mce.2012.05.002_b0195","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jacc.2007.09.058","article-title":"Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes","volume":"51","author":"Omland","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.mce.2012.05.002_b0200","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bbrc.2005.01.122","article-title":"Inflammatory cytokines activate p38 MAPK to induce osteoprotegerin synthesis by MG-63 cells","volume":"329","author":"Pantouli","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2012.05.002_b0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s002239900125","article-title":"Regulation of murine osteoblast macrophage colony-stimulating factor production by 1,25(OH)2D3","volume":"59","author":"Rubin","year":"1996","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.mce.2012.05.002_b0210","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/endo.139.3.5778","article-title":"Dexamethasone promotes expression of membrane-bound macrophage colony-stimulating factor in murine osteoblast-like cells","volume":"139","author":"Rubin","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2012.05.002_b0215","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.bone.2006.01.151","article-title":"Ibandronate: pharmacology and preclinical studies","volume":"38","author":"Russell","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.mce.2012.05.002_b0220","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1196\/annals.1402.027","article-title":"ERK signaling regulates macrophage colony-stimulating factor expression induced by titanium particles in MC3T3-E1 murine calvarial preosteoblastic cells","volume":"1117","author":"Seo","year":"2007","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.mce.2012.05.002_b0225","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/109158180302200512","article-title":"A toxicity profile of osteoprotegerin in the cynomolgus monkey","volume":"22","author":"Smith","year":"2003","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.mce.2012.05.002_b0230","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/pds.984","article-title":"Statin lipid-lowering drugs and bone mineral density","volume":"14","author":"Solomon","year":"2005","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.mce.2012.05.002_b0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hon.869","article-title":"A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma","volume":"27","author":"Sondergaard","year":"2009","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.mce.2012.05.002_b0240","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10585-010-9342-z","article-title":"Nitrogen-containing bisphosphonate, YM529\/ONO-5920, inhibits tumor metastasis in mouse melanoma through suppression of the Rho\/ROCK pathway","volume":"27","author":"Tanimori","year":"2010","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.mce.2012.05.002_b0245","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0301-472X(99)00011-9","article-title":"CD9 molecule expressed on stromal cells is involved in osteoclastogenesis","volume":"27","author":"Tanio","year":"1999","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.mce.2012.05.002_b0250","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3109\/s10165-007-0566-y","article-title":"Minodronic acid influences receptor activator of nuclear factor kappaB ligand expression and suppresses bone resorption by osteoclasts in rats with collagen-induced arthritis","volume":"17","author":"Tanishima","year":"2007","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.mce.2012.05.002_b0255","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejogrb.2004.08.007","article-title":"Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women","volume":"120","author":"Tanriverdi","year":"2005","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.mce.2012.05.002_b0260","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11010-007-9485-7","article-title":"Macrophage inflammatory protein-1alpha (MIP-1alpha) enhances a receptor activator of nuclear factor kappaB ligand (RANKL) expression in mouse bone marrow stromal cells and osteoblasts through MAPK and PI3K\/Akt pathways","volume":"304","author":"Tsubaki","year":"2007","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.mce.2012.05.002_b0265","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1349-7006.2007.00651.x","article-title":"Nitrogen-containing bisphosphonate, YM529\/ONO-5920, inhibits macrophage inflammatory protein 1 alpha expression and secretion in mouse myeloma cells","volume":"99","author":"Tsubaki","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.mce.2012.05.002_b0270","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cyto.2011.01.005","article-title":"Blockade of the Ras\/MEK\/ERK and Ras\/PI3K\/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-\u03b2 as angiogenic factors in mouse osteosarcoma","volume":"54","author":"Tsubaki","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.mce.2012.05.002_b0275","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.bone.2007.02.019","article-title":"Effects of statins on bone mineral density: a meta-analysis of clinical studies","volume":"40","author":"Uzzan","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.mce.2012.05.002_b0280","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1210\/jc.2007-0646","article-title":"The role of receptor activator of nuclear factor-kappaB (RANK)\/RANK ligand\/osteoprotegerin: clinical implications","volume":"92","author":"Vega","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2012.05.002_b0285","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1006\/bbrc.2002.6510","article-title":"Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts","volume":"291","author":"Viereck","year":"2002","journal-title":"Biochem. Biophy. Res. Commun."},{"key":"10.1016\/j.mce.2012.05.002_b0290","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/jcb.20598","article-title":"Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts","volume":"96","author":"Viereck","year":"2005","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.mce.2012.05.002_b0295","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1016\/j.biomaterials.2005.02.008","article-title":"Promotion of bone formation by simvastatin in polyethylene particle-induced osteolysis","volume":"26","author":"von Knoch","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.mce.2012.05.002_b0300","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1749-799X-6-34","article-title":"Alendronate (ALN) combined with osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats","volume":"6","author":"Wang","year":"2011","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.mce.2012.05.002_b0305","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1359\/jbmr.2000.15.4.650","article-title":"Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts","volume":"15","author":"Woo","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.mce.2012.05.002_b0310","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1756-9966-30-74","article-title":"Statin-induced apoptosis via the suppression of ERK1\/2 and Akt activation by inhibition of the geranylgeranyl-pyrophosphate biosynthesis in glioblastoma","volume":"30","author":"Yanae","year":"2011","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.mce.2012.05.002_b0315","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/gme.0b013e3181d3e036","article-title":"Statins and bone health in postmenopausal women: a systematic review of randomized controlled trials","volume":"17","author":"Yue","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.mce.2012.05.002_b0320","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1749-799X-5-37","article-title":"Transcriptional regulation of bone formation by the osteoblast-specific transcription factor Osx","volume":"5","author":"Zhang","year":"2010","journal-title":"J. Orthop. Surg. Res."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720712002687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720712002687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:02:07Z","timestamp":1759586527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720712002687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":64,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0303720712002687"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2012.05.002","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bisphosphonate- and statin-induced enhancement of OPG expression and inhibition of CD9, M-CSF, and RANKL expressions via inhibition of the Ras\/MEK\/ERK pathway and activation of p38MAPK in mouse bone marrow stromal cell line ST2","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2012.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}